3L, 5L, What the L? A NICE Conundrum

Pharmacoeconomics. 2018 Jun;36(6):637-640. doi: 10.1007/s40273-018-0622-9.

Authors

Nancy Devlin^{1

2}, John Brazier³, A Simon Pickard⁴, Elly Stolk⁵

Affiliations

¹ Office of Health Economics, 105 Victoria Street, London, SW1B 6QT, UK. [email protected].
² School of Health and Related Research, University of Sheffield, Sheffield, UK. [email protected].
³ School of Health and Related Research, University of Sheffield, Sheffield, UK.
⁴ Department of Pharmacy Systems, Outcomes and Policy, University of Illinois, Chicago, IL, USA.
⁵ EuroQol Research Foundation, Rotterdam, The Netherlands.

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Cost-Benefit Analysis / standards*
Health Status*
Humans
Quality-Adjusted Life Years*
Surveys and Questionnaires / standards*